Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aimovig And Tegsedi In Raft Of Products To Get EMA Thumbs up

Jun 01 2018

• By Neena Brizmohun

3d render of Europe map Earth globe — Nine new products have been recommended for approval across the EU

Related Content

EU Green Light In Sight For Aimovig; 12 Drugs In Line For Potential CHMP Decision

May 29 2018

Gilead's Biktarvy Set For EU Approval

Apr 30 2018

Liver Damage Worries Lead To Further EU Restrictions On Richter’s Esmya

May 21 2018

Pfizer's Xeljanz Pushed By New Tailwind From Approval In Ulcerative Colitis

May 30 2018

Related Companies

Novartis AG

Amgen, Inc.

Akcea Therapeutics, Inc.

Aegerion Pharmaceuticals, Inc.

Otsuka Holdings Co., Ltd.

Novartis AG

AbbVie Inc.

Pfizer Inc.

Roche Holding AG

Sarepta Therapeutics, Inc.

Ablynx N.V.

Takeda Pharmaceutical Co. Ltd.

PTC Therapeutics, Inc.

AB Science S.A.

Merck & Co., Inc.

Gedeon Richter Plc.

Ionis Pharmaceuticals, Inc.

Additional Topics

Europe Drug Review Drug Safety Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window